TechNation Radio Podcast

In this week’s Tech Nation, Moira speaks with Dr. Andrew Steele in a FOLLOW-ON science-focused interview on the latest science behind aging. His book is “Ageless … The New Science of Getting Older without Getting Old.” And then, an excerpt from Dr. Thomas Rando’s 2020 interview. A co-founder of Fountain Therapeutics, he tells us about their science and their efforts to potentially reverse the aging process.

On this week’s Tech Nation, Moira speaks with Journalists Dade Hayes & Dawn Chmielewski about “Binge Times: Inside Hollywood’s Furious Billion-Dollar Battle to Take Down Netflix”. From the stock plunge of Netflix to the rise of Bridgerton, it’s a streaming war for our attention. Then in Biotech, could “sticky proteins” lead to Alzheimer’s, Parkinson’s, ALS and more? Dr. Maria Maccecchini, Founder, President and CEO of Annovis Bio, tells us about their approach.

On this week’s Tech Nation, Moira speaks with Neuroscientist Daniel Levitin about his book “Successful Aging … A Neuroscientist Explores the Power and Potential of Our Lives”. And Dr. Cameron Turtle from Eidos Therapeutics tells us that of the 6 Million Americans living with the medical condition known as Heart Failure, several hundred thousand have a special type, which was thought to be rare, but is being underdiagnosed. It’s known by its initials: ATTR. Eidos is working on a treatment.

On this week’s Tech Nation, it’s all about changing behaviors now that that we interact online. Erica Dhawan talks about “Digital Body Language - How to Build Trust & Connection No Matter the Distance”. Then how to take an insight in science and enable it to become an actual product. Dr. Mark Allen, the co-founder and CEO of Elevian, tells us their experience and about selecting their first target: stroke.

On this week’s Tech Nation, Moira speaks with Journalist and NPR contributor Keith O’Brien about his book, “Paradise Falls: The True Story of an Environmental Catastrophe”. From congressional aides to housewives to defiant scientists – we receive the benefits of the challenge of Love Canal. Then, new science leads to understanding natural repair mechanisms in the brain. Dr. Mark Litton is the President and CEO of Athira Pharma. He discusses their efforts in Alzheimer’s and Parkinson’s dementia.

Dr. Amit (Am-it) Kumar, the President and CEO of Anixa Biosciences, about a new approach to actually preventing the truly aggressive triple negative breast cancer, and its potential for other breast cancers and ovarian cancer. We hear about the scientific breakthroughs and their partnership with the Cleveland Clinic. Then, Sarah Frier (“Fry-er”), a tech journalist with Bloomberg News. Her award-winning book: “No Filter: The Inside Story of Instagram” has lessons for today’s potential buyout of Twitter.

On this week’s Tech Nation, Moira speaks with Margrethe Vestager, the Executive Vice President of the European Commission for “A Europe Fit for the Digital Age”.  Commissioner Vestager describes why the EU imposed fines on such digital giants as Google and Amazon, and the impact on the EU’s digital space since the Russian invasion of Ukraine. Then, University of the South Professor David George Haskell talks about sound – from the beginning of time on planet earth to the sounds in our teeming cities. His book is “Sounds Wild and Broken … Sonic Marvels, Evolution’s Creativity and the Crisis of Sensory Extinction”.

On this week’s Tech Nation, Moira speaks with

Wall Street Journal investigative journalists, Kirsten Grind and Katherine Sayre. Their book is “Happy at Any Cost … The Revolutionary Vision and Fatal Quest of Zappos CEO Tony Hsieh”. Then neuroscience tells us - it’s all about the messenger and not the message. Stephen Martin and Joseph Marks talk about their 2019 book, “Messengers: Who We Listen To, Who We Don’t, and Why”.

On this week’s Tech Nation, Moira speaks with

Dr. Cathy O’Neil about “The Shame Machine … Who Profits in the New Age of Humiliation”. They talk about how encouraging shame figures into the algorithms of social media. Then Dr. Daniel Bloomfield, the Chief Medical Officer of Anthos Therapeutics, describes the current challenge of preventing bleeding while avoiding the specter of clotting. Anthos may have a solution.

On this week’s Tech Nation, Moira speaks with

Dr. Stewart Campbell, CEO of Axial Therapeutics, about their groundbreaking work in Autism–related irritability in teenagers, in Parkinson’s, and in complementing the latest cancer treatments. Then Dr. Ray Stevens, CEO of ShouTi Pharma, talks about their approach in
turning IV drugs into pills. Current projects include Diabetes and obesity, and two Pulmonary and Cardiovascular disorders. And these are just their first candidates …